Postpartum hemorrhage, molar pregnancy, abortion, placenta previa, placental abruption,vasa previa, ectopic pregnancy. Explain in detail

Reading File

This covers major obstetric emergencies and early-pregnancy complications. I can provide a focused detailed note on one topic at a time.

Postpartum hemorrhage (PPH): definition, causes using the 4 Ts, immediate resuscitation, uterotonics, tranexamic acid, tamponade, surgery, and prevention.
Molar pregnancy: complete versus partial mole, clinical features, diagnosis, evacuation, hCG surveillance, and gestational trophoblastic neoplasia.
Abortion/miscarriage: terminology, types, diagnosis, expectant-medical-surgical management, and Rh prophylaxis.
Placenta previa: painless antepartum bleeding, ultrasound diagnosis, precautions, delivery planning, and hemorrhage risk.
Placental abruption: painful bleeding, concealed hemorrhage, maternal-fetal complications, diagnosis, and urgent management.
Vasa previa: fetal-vessel anatomy, antenatal screening, fetal hemorrhage after membrane rupture, and planned cesarean delivery.
Ectopic pregnancy: risk factors, β-hCG and ultrasound interpretation, expectant versus methotrexate versus surgical treatment, and rupture management.

At a high level, placenta previa, abruption, and vasa previa are causes of antepartum hemorrhage. Molar pregnancy, miscarriage, and ectopic pregnancy concern early pregnancy loss or abnormal implantation. PPH is bleeding after birth and requires simultaneous resuscitation and treatment of the cause. These conditions can become life-threatening, so any heavy vaginal bleeding, severe abdominal pain, fainting, shoulder-tip pain, or reduced fetal movements needs emergency assessment.

Asking for Preferences

Which topic should I explain first in full detail?

This covers major obstetric emergencies and early-pregnancy complications. I can provide a focused detailed note on one topic at a time.

Postpartum hemorrhage (PPH): definition, causes using the 4 Ts, immediate resuscitation, uterotonics, tranexamic acid, tamponade, surgery, and prevention.
Molar pregnancy: complete versus partial mole, clinical features, diagnosis, evacuation, hCG surveillance, and gestational trophoblastic neoplasia.
Abortion/miscarriage: terminology, types, diagnosis, expectant-medical-surgical management, and Rh prophylaxis.
Placenta previa: painless antepartum bleeding, ultrasound diagnosis, precautions, delivery planning, and hemorrhage risk.
Placental abruption: painful bleeding, concealed hemorrhage, maternal-fetal complications, diagnosis, and urgent management.
Vasa previa: fetal-vessel anatomy, antenatal screening, fetal hemorrhage after membrane rupture, and planned cesarean delivery.
Ectopic pregnancy: risk factors, β-hCG and ultrasound interpretation, expectant versus methotrexate versus surgical treatment, and rupture management.

Explain every topic in detail

Postpartum hemorrhage (PPH)
Definition, primary versus secondary PPH, causes using the 4 Ts (tone, trauma, tissue, thrombin), resuscitation, medications, procedures, blood products, and prevention.
Molar pregnancy (hydatidiform mole)
Complete and partial mole, clinical features, ultrasound and hCG findings, uterine evacuation, follow-up, and risk of gestational trophoblastic neoplasia.
Abortion / miscarriage
Definitions and types: threatened, inevitable, incomplete, complete, missed, septic, and recurrent miscarriage; diagnosis, management options, complications, and anti-D immunoglobulin.
Placenta previa
Types/placental location, risk factors, painless antepartum bleeding, ultrasound diagnosis, counseling, and timing/mode of delivery.
Placental abruption
Premature placental separation, painful bleeding, concealed abruption, fetal compromise, DIC, stabilization, and delivery decisions.
Vasa previa
Fetal vessels crossing near the cervix, risk factors, antenatal ultrasound diagnosis, catastrophic bleeding after membrane rupture, and planned cesarean delivery.
Ectopic pregnancy
Tubal and non-tubal implantation, presentation, β-hCG and transvaginal ultrasound assessment, expectant management, methotrexate, surgery, and ruptured ectopic emergency care.

These are all potentially time-critical obstetric conditions. Heavy bleeding in pregnancy or after delivery, severe abdominal pain, fainting, shoulder-tip pain, fever after miscarriage, or reduced fetal movements warrants emergency care. The core distinction in antepartum bleeding is that previa is typically painless, abruption is usually painful with a tender/rigid uterus, and vasa previa presents with fetal bleeding when membranes rupture.

Asking for Preferences

Which topic should I explain in full detail next?

This covers major obstetric emergencies and early-pregnancy complications. I can provide a focused detailed note on one topic at a time.

Postpartum hemorrhage (PPH): definition, causes using the 4 Ts, immediate resuscitation, uterotonics, tranexamic acid, tamponade, surgery, and prevention.
Molar pregnancy: complete versus partial mole, clinical features, diagnosis, evacuation, hCG surveillance, and gestational trophoblastic neoplasia.
Abortion/miscarriage: terminology, types, diagnosis, expectant-medical-surgical management, and Rh prophylaxis.
Placenta previa: painless antepartum bleeding, ultrasound diagnosis, precautions, delivery planning, and hemorrhage risk.
Placental abruption: painful bleeding, concealed hemorrhage, maternal-fetal complications, diagnosis, and urgent management.
Vasa previa: fetal-vessel anatomy, antenatal screening, fetal hemorrhage after membrane rupture, and planned cesarean delivery.
Ectopic pregnancy: risk factors, β-hCG and ultrasound interpretation, expectant versus methotrexate versus surgical treatment, and rupture management.

Molar pregnancy (hydatidiform mole)
Complete and partial mole, clinical features, ultrasound and hCG findings, uterine evacuation, follow-up, and risk of gestational trophoblastic neoplasia.
Abortion / miscarriage
Definitions and types: threatened, inevitable, incomplete, complete, missed, septic, and recurrent miscarriage; diagnosis, management options, complications, and anti-D immunoglobulin.
Placenta previa
Types/placental location, risk factors, painless antepartum bleeding, ultrasound diagnosis, counseling, and timing/mode of delivery.
Placental abruption
Premature placental separation, painful bleeding, concealed abruption, fetal compromise, DIC, stabilization, and delivery decisions.
Vasa previa
Fetal vessels crossing near the cervix, risk factors, antenatal ultrasound diagnosis, catastrophic bleeding after membrane rupture, and planned cesarean delivery.
Ectopic pregnancy
Tubal and non-tubal implantation, presentation, β-hCG and transvaginal ultrasound assessment, expectant management, methotrexate, surgery, and ruptured ectopic emergency care.

Reading File

Finding Sources

Searching PubMed

postpartum hemorrhage AND management

Searching the Web

ACOG postpartum hemorrhage placenta previa placental abruption vasa previa ectopic pregnancy guidance

Finding Sources

Searching PubMed

postpartum hemorrhage AND tranexamic acid

Reading File

Searching the Web

WHO postpartum haemorrhage prevention diagnosis treatment guideline tranexamic acid 2025

Searching the Web

ACOG ectopic pregnancy methotrexate placenta previa vasa previa clinical guidance

Searching Images

medical diagram placenta previa placental abruption and vasa previa comparison

Finding Sources

Overview

These conditions fall into three clinical groups:

Group	Conditions
Bleeding after birth	Postpartum hemorrhage
Early-pregnancy complications	Molar pregnancy, miscarriage (spontaneous abortion), ectopic pregnancy
Bleeding in the second half of pregnancy	Placenta previa, placental abruption, vasa previa

Emergency warning: Heavy bleeding, severe one-sided or generalized abdominal pain, shoulder-tip pain, dizziness/fainting, fever after pregnancy loss, rupture of membranes with bleeding, or reduced fetal movements require urgent obstetric assessment.

1. Postpartum hemorrhage

Definition

Postpartum hemorrhage (PPH) is excessive bleeding after childbirth.

A common modern definition is cumulative blood loss of at least 1,000 mL, or any blood loss with signs/symptoms of hypovolemia, within 24 hours after birth.
Primary PPH: within the first 24 hours after delivery.
Secondary PPH: from 24 hours to 6 weeks postpartum.

Pregnancy increases circulating blood volume, so a woman may lose a large amount of blood before becoming hypotensive. Early tachycardia, pallor, dizziness, reduced urine output, or altered consciousness are important warning signs.

Causes: the “4 Ts”

Cause	Meaning	Examples
Tone	Uterus fails to contract	Uterine atony, the commonest cause
Trauma	Genital-tract injury	Cervical/vaginal/perineal tear, uterine rupture, uterine inversion
Tissue	Retained or abnormally adherent placental tissue	Retained placenta, retained products, placenta accreta spectrum
Thrombin	Coagulation disorder	DIC, severe abruption, inherited bleeding disorder, anticoagulation

Uterine atony

Normally, contraction of uterine muscle fibers compresses the blood vessels at the placental bed, termed the “living ligature” mechanism. In uterine atony, the uterus remains soft and poorly contracted, so these vessels bleed freely.

Risk factors

Overdistended uterus: multiple pregnancy, polyhydramnios, macrosomia
Prolonged or very rapid labor
Oxytocin exposure or uterine muscle fatigue
Chorioamnionitis
Grand multiparity
Magnesium sulfate or some anesthetic agents
Retained placenta
Prior PPH

Recognition

Excessive vaginal bleeding
Boggy, enlarged uterus, especially in atony
Continued bleeding despite uterine massage
Tachycardia, hypotension, pallor, confusion
A firm uterus with bleeding suggests trauma or retained tissue rather than atony.

Immediate management

PPH must be treated as a simultaneous resuscitation and cause-control emergency.

Call for help: obstetric, anesthesia, blood bank, operating theatre staff.
Assess ABCs: airway, breathing, circulation; give oxygen if needed.
Two large-bore IV cannulas.
Send blood for CBC, group and crossmatch, coagulation tests, fibrinogen, electrolytes, and blood gas where appropriate.
Begin rapid warmed crystalloid while arranging blood products; activate a massive transfusion protocol for severe hemorrhage.
Quantify blood loss and monitor pulse, blood pressure, urine output, mental state, and temperature.
Identify the cause using the 4 Ts.

If uterine atony is suspected

Empty the bladder.
Perform uterine massage and bimanual uterine compression.
Start a uterotonic, usually oxytocin.
Add further uterotonics depending on contraindications:
- Ergometrine/methylergometrine: avoid in hypertension or preeclampsia.
- Carboprost: avoid in asthma and use cautiously in cardiac, hepatic, or renal disease.
- Misoprostol: may be used when injectable uterotonics are unavailable or as an adjunct.
Give tranexamic acid (TXA) as early as possible and within 3 hours of birth for established PPH, unless contraindicated. The 2024 individual-patient meta-analysis supports early TXA treatment without an apparent increase in thromboembolic events in trial populations (Ker et al., 2024).

If bleeding continues

Inspect the cervix, vagina, and perineum and repair lacerations.
Manually remove retained placenta or retained tissue when indicated.
Give blood components guided by clinical bleeding and laboratory results. In severe PPH, early attention to fibrinogen is important.
Use uterine balloon tamponade if bleeding from atony persists despite first-line measures and appropriate resources are available.
Escalate to surgical/interventional treatment:
- Compression sutures, such as B-Lynch suture
- Uterine artery ligation or internal iliac artery ligation
- Uterine artery embolization, if stable and rapidly available
- Hysterectomy if hemorrhage is uncontrollable or placenta accreta spectrum is present

The current WHO PPH guideline emphasizes standardized treatment bundles using uterotonics, TXA, IV fluids, assessment for trauma/tissue, monitoring, and escalation where needed.

Secondary PPH

Usually caused by:

Retained products of conception
Infection, especially endometritis
Subinvolution of the placental site
Breakdown/infection of genital-tract wounds
Less commonly, a coagulation disorder

Assessment includes examination, ultrasound when indicated, CBC, infection assessment, antibiotics if infection is suspected, and uterine evacuation only when clinically indicated.

Prevention

Identify antenatal risk factors.
Active management of the third stage of labor.
Prophylactic uterotonic, commonly oxytocin, after delivery.
Deliver high-risk patients where blood products, anesthesia, surgery, and critical care are available.

2. Molar pregnancy

Definition

A molar pregnancy, also called a hydatidiform mole, is an abnormal gestation caused by abnormal fertilization and abnormal trophoblastic proliferation. The placental chorionic villi become swollen and cystic, producing a grape-like appearance.

It is part of gestational trophoblastic disease (GTD). Some cases persist as gestational trophoblastic neoplasia (GTN), which needs oncology follow-up and chemotherapy.

Types

Feature	Complete mole	Partial mole
Fetal tissue	Absent	Often present but abnormal/nonviable
Genetic pattern	Usually androgenetic diploid, commonly 46,XX	Usually triploid, commonly 69,XXY
Fertilization	Empty ovum fertilized, with paternal genome duplication or two sperm	Normal ovum fertilized by two sperm
Trophoblastic proliferation	Diffuse and marked	Focal, less marked
hCG	Often markedly elevated	Less markedly elevated
Uterine size	Often larger than dates	Often normal or smaller than dates
Persistent GTN risk	Higher	Lower

A complete mole has paternal genetic material with no viable embryo. A partial mole has an abnormal triploid conceptus and may resemble a missed or incomplete miscarriage. Berek & Novak describes complete moles as typically androgenetic diploid and partial moles as typically triploid.

Risk factors

Previous molar pregnancy
Extremes of maternal age, especially very young or older reproductive age
Prior pregnancy loss in some populations
Rare familial recurrent molar pregnancy syndromes

Clinical features

Vaginal bleeding in the first trimester
Uterus larger than expected for dates, especially in complete mole
Excessive nausea/vomiting due to high hCG
Passage of grape-like vesicles, now uncommon because diagnosis is often earlier
Early-onset preeclampsia, especially before 20 weeks
Hyperthyroid features: tremor, tachycardia, heat intolerance
Theca-lutein ovarian cysts
No fetal heart activity in complete mole

Diagnosis

Quantitative serum β-hCG
Transvaginal ultrasound
- Complete mole: diffuse echogenic intrauterine mass with multiple small cystic spaces, classically “snowstorm” appearance; no fetus.
- Partial mole: may show gestational sac/fetal tissue with cystic placental changes.
Histopathology after evacuation confirms the diagnosis.
Baseline assessment may include CBC, blood group/Rh status, renal/liver function, thyroid function if clinically indicated, and chest imaging if GTN is suspected.

Management

Initial treatment

Stabilize if heavy bleeding or severe hyperemesis/preeclampsia occurs.
Suction evacuation/curettage is usually the preferred fertility-preserving treatment.
Send all tissue for histopathology.
Give anti-D immunoglobulin to an unsensitized Rh-negative patient according to local guidance.
Hysterectomy may be considered in selected patients who do not desire fertility, but it does not remove the need for hCG follow-up.

hCG surveillance

Serial quantitative hCG measurement is essential because hCG should progressively fall to normal after complete evacuation.

Persistent or rising hCG may indicate postmolar GTN.

Features suggesting GTN

hCG level plateaus over serial measurements
hCG rises over serial measurements
hCG remains detectable for a prolonged period
Histologic choriocarcinoma
Metastatic disease

Patients should avoid pregnancy during the surveillance interval because a new pregnancy raises hCG and makes recurrence/persistence difficult to detect. Use reliable contraception as advised by the treating trophoblastic-disease center.

Prognosis

Most molar pregnancies resolve after evacuation and surveillance. GTN is highly treatable, including many metastatic cases, when identified promptly.

3. Abortion / miscarriage

Terminology

In clinical obstetrics, spontaneous abortion means miscarriage, or spontaneous loss of an intrauterine pregnancy before fetal viability. The gestational-age threshold differs by country, often before 20 to 24 weeks.

“Abortion” can also refer to induced termination of pregnancy, but the conditions below refer to spontaneous miscarriage.

Main causes

Most first-trimester miscarriages are caused by fetal chromosomal abnormalities. Other contributors include:

Uterine anomalies
Antiphospholipid syndrome
Uncontrolled diabetes or thyroid disease
Severe infection, though less common
Cervical insufficiency in later losses
Lifestyle factors such as smoking
Increasing maternal age

A single early miscarriage is common and usually does not mean infertility or a recurrent problem.

Types of miscarriage

Type	Cervix	Fetal cardiac activity / retained tissue	Typical features
Threatened miscarriage	Closed	Pregnancy may still be viable	Bleeding with or without mild cramps
Inevitable miscarriage	Open	Pregnancy cannot continue	Bleeding, cramps, dilated cervix
Incomplete miscarriage	Open	Some products expelled, some retained	Heavy bleeding, pain, retained tissue
Complete miscarriage	Closed after expulsion	Uterus empty or nearly empty	Bleeding/pain settle after tissue passes
Missed miscarriage	Usually closed	Nonviable intrauterine pregnancy retained	Minimal bleeding or no symptoms
Septic miscarriage	Variable	Infected retained tissue may be present	Fever, uterine tenderness, foul discharge, systemic illness
Recurrent pregnancy loss	Not a clinical type of acute miscarriage	Usually defined by repeated losses	Requires targeted evaluation

Evaluation

Assess hemodynamic stability: pulse, blood pressure, ongoing blood loss.
Ask about pain, bleeding, tissue passage, fever, pregnancy dates, ectopic risk factors, and Rh status.
Perform abdominal and pelvic examination when appropriate.
Transvaginal ultrasound to establish intrauterine pregnancy, viability, retained tissue, and exclude ectopic pregnancy.
Quantitative β-hCG may be repeated if ultrasound findings are inconclusive.
CBC and blood group/Rh testing if bleeding is significant.

A pregnancy of uncertain viability or pregnancy of unknown location should not be labeled miscarriage prematurely. Repeat ultrasound and serial hCG can be necessary.

Management

Threatened miscarriage

Confirm viability and exclude ectopic pregnancy.
Expectant management and safety-net advice are common.
Progesterone may be considered in selected women with early bleeding and a history of previous miscarriage, depending on local protocol.
Advise urgent review for increasing pain, bleeding, syncope, or fever.

Complete miscarriage

Usually needs no uterine intervention if the patient is stable, bleeding has settled, and ultrasound/clinical assessment supports complete passage.
Follow-up confirms symptom resolution and, when needed, hCG decline.

Incomplete or missed miscarriage

Three options are generally available if the patient is stable and infection is absent:

Expectant management
Allowing spontaneous passage of tissue.
Medical management
Usually with misoprostol, sometimes preceded by mifepristone depending on guideline and availability.
Surgical uterine evacuation
Vacuum aspiration or suction curettage. It is indicated sooner for hemodynamic instability, heavy uncontrolled bleeding, infection, suspected molar pregnancy, or patient preference.

Septic miscarriage

This is an emergency.

Broad-spectrum IV antibiotics
IV fluids and resuscitation
Prompt uterine evacuation once stabilized
Culture tests and management of sepsis
Escalation to critical care if shock or organ dysfunction occurs

Rh prophylaxis

Give anti-D immunoglobulin to unsensitized Rh-negative patients according to gestation, bleeding severity, and local guidance, particularly after surgical management or later first-trimester/second-trimester loss.

Recurrent pregnancy loss

Repeated miscarriages merit evaluation for:

Antiphospholipid syndrome
Uterine cavity abnormalities
Parental chromosomal rearrangements in selected cases
Thyroid disease and diabetes where relevant
Products-of-conception genetic testing in selected cases

4. Placenta previa

Definition

Placenta previa occurs when the placenta implants in the lower uterine segment and lies over, partially over, or very close to the internal cervical os.

Current ultrasound reporting commonly describes:

Placenta previa: placenta covers the internal os.
Low-lying placenta: placental edge is close to, but does not cover, the internal os.

Older classifications include complete, partial, and marginal previa.

Pathophysiology

As the lower uterine segment stretches in late pregnancy and the cervix begins to efface/dilate, the placental attachment may shear. This causes maternal bleeding from the placental bed.

Risk factors

Previous cesarean birth
Previous placenta previa
Prior uterine surgery or curettage
Multiparity
Multiple pregnancy
Advanced maternal age
Smoking or cocaine use
Assisted reproduction

A placenta previa with a prior cesarean scar increases concern for placenta accreta spectrum, in which the placenta is abnormally adherent or invasive.

Clinical features

Painless, bright-red vaginal bleeding in the second half of pregnancy
Bleeding may stop and recur
Usually a soft, non-tender uterus
Fetal malpresentation, particularly breech or transverse lie, may occur

Diagnosis

Ultrasound establishes placental location.
Transvaginal ultrasound is safe and provides the most accurate assessment of the relationship between placenta and internal os.
A low placenta identified at the mid-pregnancy scan often resolves later because expansion of the lower uterine segment moves the placental edge away from the os.

Critical precaution

Do not perform a digital vaginal examination until placenta previa has been excluded by ultrasound. A digital examination can disrupt placental attachment and trigger severe hemorrhage.

Management

Acute bleeding

Maternal stabilization: two IV lines, CBC, coagulation screen, blood group/crossmatch.
Continuous fetal assessment if gestation is viable.
Ultrasound assessment.
Anti-D for Rh-negative unsensitized patients as appropriate.
Obstetric consultation and admission if bleeding is significant or recurrent.

Ongoing care

Management depends on:

Amount and recurrence of bleeding
Gestational age
Placental position
Fetal status
Labor or rupture of membranes
Access to emergency care

A patient with persistent placenta previa generally requires cesarean birth, often planned before labor begins. Timing is individualized based on bleeding and maternal-fetal status. Heavy ongoing bleeding, maternal instability, labor with significant previa, or fetal compromise requires urgent delivery.

5. Placental abruption

Definition

Placental abruption, or abruptio placentae, is premature separation of a normally implanted placenta from the uterine wall before birth.

Bleeding can be:

Revealed: blood exits through the vagina.
Concealed: blood accumulates behind the placenta, so visible bleeding may be minimal despite severe maternal and fetal compromise.
Mixed: both concealed and vaginal bleeding occur.

Pathophysiology

Separation of the placenta causes bleeding into the decidua and behind the placenta. This reduces placental gas/nutrient exchange, causing fetal hypoxia. Severe abruption can consume clotting factors and trigger DIC.

Risk factors

Hypertension, preeclampsia
Previous abruption
Maternal trauma, including road traffic collision or intimate-partner violence
Cocaine use and smoking
Prelabor rupture of membranes
Chorioamnionitis
Multifetal pregnancy
Sudden uterine decompression, such as after rupture of membranes with polyhydramnios
Thrombophilia in selected cases

Clinical features

Painful vaginal bleeding
Constant abdominal pain or back pain
Uterine tenderness
Tense, rigid, “board-like” uterus
Frequent uterine contractions
Reduced fetal movements
Nonreassuring fetal heart tracing or fetal death in severe cases
Maternal shock that seems disproportionate to visible bleeding, suggesting concealed hemorrhage

Not every abruption presents classically. It is largely a clinical diagnosis.

Diagnosis

Maternal evaluation and fetal monitoring are central.
CBC, blood group/crossmatch, coagulation tests, and especially fibrinogen.
Ultrasound may demonstrate retroplacental hematoma, but a normal ultrasound does not rule out abruption.
Continuous cardiotocography is used for viable pregnancies.

Complications

Maternal

Massive hemorrhage and shock
DIC
Acute kidney injury
PPH
Need for hysterectomy in severe cases
Maternal death, rarely

Fetal

Hypoxia and acidosis
Growth restriction in chronic abruption
Preterm birth
Stillbirth

Management

Stabilize mother first.
Two large-bore IV lines, blood products as required, and early obstetric/anesthetic involvement.
Continuous fetal monitoring if viable.
Correct coagulopathy with appropriate components.
Administer anti-D for Rh-negative unsensitized patients where indicated.
Immediate delivery is indicated for severe abruption, maternal instability, significant fetal compromise, or fetal death with maternal deterioration/coagulopathy.
Vaginal birth may be appropriate if delivery is imminent or fetal death has occurred and the mother is stable.
Cesarean birth is often needed for a live fetus with acute compromise when vaginal delivery is not imminent.

6. Vasa previa

Definition

Vasa previa occurs when unprotected fetal blood vessels run through the membranes over or very near the internal cervical os.

Unlike placenta previa, the threatened vessels are fetal vessels, not maternal placental tissue. When membranes rupture or the cervix dilates, these vessels can tear, causing rapid fetal hemorrhage.

Types

Type 1: vessels from a velamentous cord insertion cross the lower uterine segment.
Type 2: vessels connecting a succenturiate or bilobed placental lobe cross near the os.

Risk factors

Velamentous cord insertion
Succenturiate or bilobed placenta
Low-lying placenta or resolved placenta previa
Multiple pregnancy
In vitro fertilization/assisted reproduction

Clinical features

Antenatally, the mother may have no symptoms.

The classic intrapartum presentation is:

Rupture of membranes
Sudden painless vaginal bleeding
Acute fetal bradycardia or sinusoidal fetal heart tracing

The blood loss is fetal. Even a relatively small volume can be catastrophic because fetal blood volume is limited.

Diagnosis

Antenatal diagnosis is made with transvaginal ultrasound plus color Doppler.
The goal is to identify fetal vessels crossing or close to the internal os before labor or membrane rupture.

Management

Refer to maternal-fetal medicine/obstetric care.
Avoid labor and membrane rupture.
Plan cesarean birth before spontaneous labor, often in the late preterm period, with timing individualized to risk and local protocol.
Corticosteroids may be considered if preterm birth is expected.
In suspected vasa previa with bleeding and fetal heart-rate abnormality after membrane rupture, perform immediate emergency cesarean delivery and prepare neonatal resuscitation/transfusion.

Key distinction

Vasa previa is especially dangerous because the mother may appear relatively stable while the fetus rapidly exsanguinates.

7. Ectopic pregnancy

Definition

An ectopic pregnancy implants outside the endometrial cavity. Most are in the fallopian tube, especially the ampullary portion.

Other sites include:

Interstitial/cornual region
Cervix
Cesarean-scar pregnancy
Ovary
Abdominal cavity
Heterotopic pregnancy: simultaneous intrauterine and ectopic pregnancies, more likely after assisted reproduction

Risk factors

Previous ectopic pregnancy
Tubal surgery or sterilization
Pelvic inflammatory disease, especially chlamydial infection
Endometriosis
Assisted reproductive technology
Smoking
Intrauterine device failure: pregnancy is rare with an IUD, but if pregnancy occurs, the relative likelihood of ectopic implantation is higher
Prior abdominal/pelvic surgery

Many patients have no identifiable risk factor.

Clinical presentation

Typical symptoms occur at 6 to 10 weeks:

Amenorrhea or positive pregnancy test
Vaginal spotting/bleeding
Unilateral lower abdominal or pelvic pain

Features of rupture/hemoperitoneum:

Severe abdominal pain
Shoulder-tip pain from diaphragmatic irritation
Syncope, dizziness, weakness
Peritoneal signs
Hypotension or shock
Abdominal distension

A ruptured ectopic pregnancy is a life-threatening emergency. Absence of hypotension does not exclude significant internal bleeding.

Diagnosis

Pregnancy test

A positive pregnancy test confirms pregnancy but not its location.

Transvaginal ultrasound

Possible findings:

Definite intrauterine pregnancy excludes ectopic pregnancy in most spontaneous conceptions, but not heterotopic pregnancy.
Adnexal mass separate from the ovary
Extrauterine gestational sac/yolk sac/fetal pole
Free pelvic or intraperitoneal fluid, particularly concerning when significant

Serial quantitative β-hCG

If ultrasound does not identify an intrauterine or ectopic pregnancy, the condition is called a pregnancy of unknown location.

Serial hCG trends and repeat ultrasound are used, but hCG alone should not be used to diagnose ectopic pregnancy or to give methotrexate to a potentially viable intrauterine pregnancy.

Management

1. Emergency surgical management

Required for:

Hemodynamic instability
Suspected or confirmed rupture
Peritoneal signs or significant hemoperitoneum
Contraindication to methotrexate
Inability to attend follow-up
Often, high hCG, fetal cardiac activity outside the uterus, or a large ectopic mass, depending on circumstances

Surgery is generally laparoscopic if the patient is stable. Procedures include:

Salpingectomy: removal of affected tube
Salpingostomy: incision to remove ectopic tissue while preserving the tube in selected cases

2. Methotrexate medical treatment

Methotrexate stops trophoblastic cell growth. It may be suitable when the patient:

Is hemodynamically stable
Has no evidence of rupture
Can reliably attend serial hCG monitoring
Has no contraindication to methotrexate

Contraindications include significant liver, renal, or hematologic disease, immunodeficiency, breastfeeding, certain active pulmonary/hepatic disease, and inability to follow up. Regimens differ, but all require hCG monitoring until the level becomes undetectable.

The risk of rupture continues until hCG resolves. ACOG notes that nonruptured tubal ectopic pregnancy can often be treated with methotrexate, but an unstable patient needs prompt surgery (ACOG tubal ectopic guidance).

3. Expectant management

Rarely appropriate when:

Patient is stable and asymptomatic
hCG is very low and falling
No concerning ultrasound findings
Reliable follow-up is available

Follow-up and future fertility

Follow hCG to resolution after methotrexate and after salpingostomy.
Advise urgent review for worsening pain, shoulder pain, fainting, or heavy bleeding.
Future intrauterine pregnancy is possible, but risk of recurrent ectopic pregnancy is increased.
Early ultrasound in the next pregnancy is appropriate to confirm intrauterine implantation.

High-yield comparison: bleeding in late pregnancy

Feature	Placenta previa	Placental abruption	Vasa previa
Main source of bleeding	Maternal placental bed	Maternal placental bed behind placenta	Fetal vessels
Pain	Usually painless	Usually painful	Usually painless
Uterus	Soft, non-tender	Tender, hypertonic, possibly rigid	Usually soft
Bleeding	Bright red, may recur	Variable, may be concealed	Often occurs at membrane rupture
Fetal compromise	Possible if major bleed	Common in severe cases	Sudden, profound, often immediate
Vaginal examination	Avoid digital exam until ultrasound excludes previa	Examination only as clinically appropriate after assessment	Avoid membrane rupture/labor if diagnosed
Typical delivery approach	Cesarean if placenta covers os	Depends on maternal/fetal status and labor progress	Planned cesarean before labor; emergency cesarean if bleeding/rupture occurs

Recent-evidence note

The medical-library descriptions are consistent with recent evidence, but PPH guidance has been updated since older textbook editions. In particular, the WHO 2025 consolidated PPH guidance and the TXA meta-analysis, PMID 39461793, should guide current clinical practice alongside local obstetric protocols.

This is a shared conversation. Sign in to Orris to start your own chat.